Celldex Therapeutics Inc (USD)
CLDX
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range2.22 | 2.35
52-Wk Range2.01 | 11.62
Last Close2.32
Mkt Cap (m)38.77
Dividend yield-
ISINUS15117B2025
Volume78,594
Exchange VenueNAS

Company Profile

Celldex Therapeutics Inc is a biopharmaceutical company. The company is engaged in the development and commercialization of immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.

Key Information
Price/Earning-
Price/Book0.38
Price/Sales6.93
P/CF-
Rev Growth (3 year avg)20.29
EPS Growth (3 year avg)-
Operating Margin % -801.05
Net Margin %-1585.07
Return on Equity-83.89
Debt/Equity-

Legal Documents

Prospectus
en 09/11/2017
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)44571310
Operating Income (m)-81-122-130-133-109-76
Net Income (m)-82-118-127-129-93-151
Basic EPS-15.30-19.80-19.65-19.05-10.80-14.48
Avg. Diluted Shares Outstanding (m)5667910
Balance Sheet
USD201320142015201620172018
Current Assets (m)30520529519614599
Non Current Assets (m)42434318817157
Total Assets (m)347248338383316156
Current Liabilities (m)202430352813
Total Liabilities (m)------
Total Equity (m)320212290265236124
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-68-102-99-113-100-75
Capital Expenditure (m)-4-2-5-3-2-1
Figures are quoted in USD unless stated otherwise
-0.08 (-3.45%)
$
2.24
Last Price